RxDoctor Payments Data

Chetan Deshpande, MD

Orthopaedic Trauma · Savannah, GANPI 1871709824

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (41.2%), education and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Smith+Nephew at 36.3% of the total. Reporting peaked in 2020 at $3,733 and has fallen 53.2% since, to $1,746 in 2025. That places this record below the midpoint for orthopaedic trauma clinicians in GA, where the typical reported total is $14,838.

$9,458in general payments, 2019–2025

Across 57 payments — averaging $165.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$3K
  • Arthrex$3K
  • Medical Device Business Services, Inc.$1K
  • Team 1, LLC$1K
  • Johnson & Johnson$576
  • Bioventus LLC$110
  • plus $231 from 9 others

What the payments were for

  • Consulting fees$1,40015%
  • Travel & lodging$3,89841%
  • Food & beverage$1,59517%
  • Education$2,56427%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,458 in reported general payments places this provider in the 45th percentile of 28 orthopaedic trauma providers in Georgia.

See all orthopaedic trauma providers in Georgia

Medicare billing

Part B allowed, 2024
$298,362
Medicare patients
522
Services billed
3,341

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen123$773
Oxycodone Hcl138$743
Celecoxib75$738
Diclofenac Sodium47$642
Meloxicam238$632
Gabapentin79$620
Doxycycline Hyclate15$364
Tramadol Hcl77$243
Methocarbamol28$199
Cefadroxil25$178
Famotidine45$151
Prednisone22$94
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$71

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Savannah

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →